Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:43AM ET
167.02
Dollar change
+0.01
Percentage change
0.01
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y6.30% Shs Outstand Perf Week0.65%
SponsorVan Eck Associates Corporation ETF Type Tagsequity Return% 3Y-0.40% Total Holdings27 Perf Month0.65%
Fund Family Bond Type Tagstechnology Return% 5Y5.96% AUM454.03M Perf Quarter0.46%
IndexMVIS US Listed Biotech 25 Index Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y7.03%
Index Weighting Commodity Type Tagsmid-cap Return% SI NAV/sh Perf Year5.57%
Active/Passive Quant Type Tags- Flows% 1M-1.78% 52W Range142.51 - 171.04 Perf YTD1.03%
Dividend TTM0.71 (0.43%) ESG Type Tags- Flows% 3M-5.97% 52W High-2.35% Beta0.74
Dividend Ex-DateDec 18, 2023 Dividend Type Sector/Theme Flows% YTD-5.97% 52W Low17.20% ATR (14)1.62
Expense0.35% Structure Type Region Flows% 1Y RSI (14)58.10 Volatility0.68% 0.92%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.03 Prev Close167.01
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume9.00K Price167.02
SMA201.27% SMA501.25% SMA2004.69% Trades Volume3,512 Change0.01%
Dec-15-23 07:57PM
Apr-06-23 08:58AM
Aug-18-22 02:00PM
Jan-31-22 09:38PM
Jan-18-22 01:38PM
01:38PM Loading…
Jan-13-22 01:38PM
Jun-30-20 04:26PM
Jun-28-20 04:51PM
Jun-02-20 04:55PM
May-18-20 03:42PM
Feb-27-20 10:43AM
Feb-11-20 05:25PM
Jan-26-20 07:17PM
Dec-25-19 11:26AM
Dec-10-19 08:33AM
01:00PM Loading…
Dec-06-19 01:00PM
Dec-04-19 08:32AM
Dec-02-19 02:40PM
Nov-26-19 07:06PM
Nov-22-19 05:15PM
Nov-21-19 12:56PM
09:40AM
Nov-11-19 02:30PM
Nov-04-19 05:05PM
01:00PM
Sep-03-19 05:46PM
Aug-27-19 10:05AM
Aug-06-19 04:22PM
Jun-26-19 11:00AM
Jun-19-19 11:49AM
07:00AM Loading…
May-17-19 07:00AM
May-07-19 04:57PM
Apr-24-19 04:04PM
Apr-05-19 08:00AM
Feb-25-19 10:15AM
Feb-14-19 01:00PM
Jan-24-19 01:00PM
11:34AM
Jan-04-19 10:01AM
Nov-16-18 05:52PM
Oct-17-18 11:48AM
Aug-02-18 12:55PM
Jul-06-18 01:50PM
Jun-27-18 12:15PM
Mar-19-18 04:15PM
Jan-25-18 09:55AM
Jan-10-18 05:40PM
Jan-09-18 11:55AM
Dec-15-17 06:56PM
Nov-22-17 05:30PM
Oct-03-17 06:31AM
Sep-18-17 12:36PM
Sep-11-17 12:05PM
Sep-06-17 09:30AM
Aug-30-17 06:50PM
Aug-24-17 10:36AM
Aug-22-17 02:05PM
Aug-21-17 03:11PM
Aug-03-17 08:24AM
08:15AM
Aug-01-17 10:38AM
12:26AM
Jul-14-17 09:59AM
Jul-13-17 05:33PM
Jul-11-17 07:36AM
Jun-28-17 04:32PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 07:36AM
Jun-13-17 09:06AM
May-31-17 09:54AM
May-15-17 06:00AM
May-13-17 01:14AM
May-11-17 03:52PM
May-10-17 05:08PM
04:24PM
May-03-17 02:58PM
Apr-07-17 11:03AM
Mar-13-17 05:46PM
05:46PM
Mar-08-17 07:07AM
Mar-07-17 09:58AM
Mar-02-17 02:00PM
09:05AM
Feb-10-17 08:38AM
Jan-27-17 04:30PM
Jan-11-17 04:27PM
11:30AM
Jan-09-17 10:36AM
Jan-03-17 10:36AM
Dec-30-16 04:16PM
Dec-28-16 06:52AM
06:49AM
Dec-16-16 06:52PM
Dec-14-16 06:33AM
06:30AM
Dec-06-16 03:54PM
Dec-01-16 01:04PM
08:04AM
Nov-30-16 09:04AM
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.